IBDEI0H0 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7659,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7659,1,3,0)
 ;;=3^Encounter for Immunization(s)
 ;;^UTILITY(U,$J,358.3,7659,1,4,0)
 ;;=4^Z23.
 ;;^UTILITY(U,$J,358.3,7659,2)
 ;;=^5062795
 ;;^UTILITY(U,$J,358.3,7660,0)
 ;;=E11.65^^39^386^20
 ;;^UTILITY(U,$J,358.3,7660,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7660,1,3,0)
 ;;=3^DM Type 2 Uncontrolled w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,7660,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,7660,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,7661,0)
 ;;=E11.649^^39^386^21
 ;;^UTILITY(U,$J,358.3,7661,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7661,1,3,0)
 ;;=3^DM Type 2 Uncontrolled w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,7661,1,4,0)
 ;;=4^E11.649
 ;;^UTILITY(U,$J,358.3,7661,2)
 ;;=^5002662
 ;;^UTILITY(U,$J,358.3,7662,0)
 ;;=I16.0^^39^386^44
 ;;^UTILITY(U,$J,358.3,7662,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7662,1,3,0)
 ;;=3^Hypertensive Urgency
 ;;^UTILITY(U,$J,358.3,7662,1,4,0)
 ;;=4^I16.0
 ;;^UTILITY(U,$J,358.3,7662,2)
 ;;=^8133013
 ;;^UTILITY(U,$J,358.3,7663,0)
 ;;=H54.8^^39^386^47
 ;;^UTILITY(U,$J,358.3,7663,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7663,1,3,0)
 ;;=3^Legal Blindness,USA Definition
 ;;^UTILITY(U,$J,358.3,7663,1,4,0)
 ;;=4^H54.8
 ;;^UTILITY(U,$J,358.3,7663,2)
 ;;=^5006369
 ;;^UTILITY(U,$J,358.3,7664,0)
 ;;=F10.10^^39^386^2
 ;;^UTILITY(U,$J,358.3,7664,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7664,1,3,0)
 ;;=3^Alcohol Abuse,Uncomplicated
 ;;^UTILITY(U,$J,358.3,7664,1,4,0)
 ;;=4^F10.10
 ;;^UTILITY(U,$J,358.3,7664,2)
 ;;=^5003068
 ;;^UTILITY(U,$J,358.3,7665,0)
 ;;=J30.9^^39^386^3
 ;;^UTILITY(U,$J,358.3,7665,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7665,1,3,0)
 ;;=3^Allergic Rhinitis,Unspec
 ;;^UTILITY(U,$J,358.3,7665,1,4,0)
 ;;=4^J30.9
 ;;^UTILITY(U,$J,358.3,7665,2)
 ;;=^5008205
 ;;^UTILITY(U,$J,358.3,7666,0)
 ;;=I48.0^^39^386^7
 ;;^UTILITY(U,$J,358.3,7666,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7666,1,3,0)
 ;;=3^Atrial Fibrillation Paroxysmal (PAF)
 ;;^UTILITY(U,$J,358.3,7666,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,7666,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,7667,0)
 ;;=N18.1^^39^386^9
 ;;^UTILITY(U,$J,358.3,7667,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7667,1,3,0)
 ;;=3^CKD,Stage 1
 ;;^UTILITY(U,$J,358.3,7667,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,7667,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,7668,0)
 ;;=N18.2^^39^386^10
 ;;^UTILITY(U,$J,358.3,7668,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7668,1,3,0)
 ;;=3^CKD,Stage 2
 ;;^UTILITY(U,$J,358.3,7668,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,7668,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,7669,0)
 ;;=N18.4^^39^386^14
 ;;^UTILITY(U,$J,358.3,7669,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7669,1,3,0)
 ;;=3^CKD,Stage 4
 ;;^UTILITY(U,$J,358.3,7669,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,7669,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,7670,0)
 ;;=N18.5^^39^386^15
 ;;^UTILITY(U,$J,358.3,7670,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7670,1,3,0)
 ;;=3^CKD,Stage 5
 ;;^UTILITY(U,$J,358.3,7670,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,7670,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,7671,0)
 ;;=N18.6^^39^386^26
 ;;^UTILITY(U,$J,358.3,7671,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7671,1,3,0)
 ;;=3^ESRD
 ;;^UTILITY(U,$J,358.3,7671,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,7671,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,7672,0)
 ;;=E11.22^^39^386^22
